The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the Minneapolis-based group Bio-Techne, according to a news release posted ...

“When I think about my body, I feel like I’m grasping at something I can’t quite reach and don’t quite understand,” writes ...

Merck offered $73 per share, implying a 24% premium to Wednesday's close Merck expects deal to close by late 2026 or early 2027 Sees about 140 million euros in cost savings by the third year after ...

SAN DIEGO, June 23 (Reuters) - U.S. biotechnology industry trade group BIO worked with the Food and Drug Administration on plans announced on Monday to speed ‌clinical trials and expects the next ...

Germany's Merck KGaA is poised to increase the size of its life sciences business, which provides tools for research, drug discovery, and manufacturing, with an $11.3 billion deal to acquire US rival ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and ...

German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade, as it looks to strengthen its life sciences business.

About 10 years ago, I was quite sympathetic — empathetic, even — to the Black Lives Matter movement in its early days. That ...

The BIO International Convention wrapped in San Diego on Wednesday after four days that marked two simultaneous thresholds for the global biopharma industry: AI drug discovery has moved from an ...

With Merck KGaA’s former electronics business lead Kai Beckmann now at the helm of the entire conglomerate, the new CEO is making his mark with a major outlay to support the company’s life sciences ...